Health-related quality of life of women with breast cancer being treated with hormone therapy: A scoping review.
Erilaine de Freitas CorpesRomel J V YanezDenise Montenegro da SilvaKauane M LeiteMilena C T MartinsMilena M VieiraCristina P R S Dos SantosAna F C FernandesRégia C M B CastroPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
In recent years there has been an increase in studies focused on health-related quality of life, and the evidence pointed to relevant information on health-related quality of life and the use of endocrine therapy, tamoxifen in combination with aromatase inhibitors, as well as aromatase inhibitor alone and the use of cyclin-dependent kinase 4 and 6.